Alerts will be sent to your verified email
Verify Email
SOLARA
|
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.31 % | 8.9 % | 13.43 % |
|
5yr Avg Net Profit Margin
|
-5.56 % | 6.28 % | 5.93 % |
|
Price to Book
|
2.79 | 1.62 | 2.28 |
|
P/E
|
124.6 | 26.03 | 28.5 |
|
5yr Avg Cash Conversion Cycle
|
115.03 Days | 37.81 Days | 12.78 Days |
|
5yr Average Interest Coverage Ratio
|
0.55 | 15.8 | 39.11 |
|
5yr Avg ROCE
|
3.01 % | 12.63 % | 15.77 % |
|
5yr Avg Operating Profit Margin
|
10.34 % | 10.64 % | 8.68 % |
|
5 yr average Debt to Equity
|
0.69 | 0.04 | 0.04 |
|
5yr CAGR Net Profit
|
n/a | -9.63 % | 3.98 % |
|
5yr Average Return on Assets
|
-2.61 % | 6.27 % | 7.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.01 % | 52.62 % | 35.65 % |
|
Share Pledged by Promoters
|
38.95 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.61 % | 8.93 % | -1.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.56 % | 0.0 | 0.0 |
|
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|---|